GILD.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
symbol | last | change | %chng | name | mcap | sector | wiki | |
---|---|---|---|---|---|---|---|---|
GILD | US | Gilead Sciences Inc |
News graph GILD.US
News chart for GILD
Bold candlesticks represent price chart. Light bars represent news sentiment.
Todays news for GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Declares $0.77 Quarterly Dividend - theenterpriseleader 2h ago - GILD - story | |
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - yahoo 3h ago - GILD - story | |
Gilead gives up on $4.9B antibody magrolimab - fiercebiotech 15h ago - GILD - story | |
Cardington softball gets home win over Mount Gilead - Morrow County Sentinel - morrowcountysentinel 20:30 Fri - GILD - story | |
Biktarvy Label Update Adds Data on Safety, Efficacy in Pregnant HIV Patients - empr 19:00 Fri - GILD - story | |
Gilead Stock Gives Up Big Gains As Covid Drug Drives Its Beat — Again - investors 17:30 Fri - GILD - story | |
FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV - wallstreet-online de 14:30 Fri - GILD - story | |
Gilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1 - rttnews 14:00 Fri - GILD - story | |
Gilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1 - finanznachrichten de 13:45 Fri - GILD - story | |
Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLC - dailypolitical 13:00 Fri - GILD - story | |
Gilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLC - tickerreport 13:00 Fri - GILD - story | |
Gilead Sciences (GILD) Announces FDA Approves Biktarvy Label Update With Data For Pregnant Adults With HIV - streetinsider 13:00 Fri - GILD - story | |
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024 - biztoc 01:00 Fri - GILD - story |
High impact previous days news for GILD ( full news )
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - yahoo Sat 27 Apr - GILD - link story | |
GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024 - biztoc Fri 26 Apr - GILD - link story | |
Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ... - yahoo Thu 25 Apr - GILD - link story | |
Galapagos (NASDAQ:GLPG) and Vivesto (OTCMKTS:OASMY) Head to Head Survey - theenterpriseleader Wed 24 Apr - GILD - link story | |
Head-To-Head Comparison: Galapagos (NASDAQ:GLPG) versus Vivesto (OTCMKTS:OASMY) - dailypolitical Wed 24 Apr - GILD - link story | |
StockNews.com Downgrades Gilead Sciences (NASDAQ:GILD) to Buy - themarketsdaily Tue 23 Apr - GILD - link story | |
Gilead Sciences' (GILD) Outperform Rating Reaffirmed at Oppenheimer - theenterpriseleader Tue 23 Apr - GILD - link story | |
Gilead Sciences, Inc. (NASDAQ:GILD) Stake Increased by MCF Advisors LLC - themarketsdaily Mon 22 Apr - GILD - link story | |
abrdn plc Raises Position in Gilead Sciences, Inc. (NASDAQ:GILD) - wkrb13 Sat 20 Apr - GILD - link story | |
Twin Capital Management Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - dailypolitical Thu 18 Apr - GILD - link story | |
Twin Capital Management Inc. Increases Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - themarketsdaily Thu 18 Apr - GILD - link story | |
Metastatic Colorectal Cancer Treatment Market Size 2024 - openpr Sun 14 Apr - GILD - link story | |
Gilead's Veklury receives NICE recommendation to treat COVID-19 in vulnerable adults and children - pmlive Fri 12 Apr - GILD - link story | |
3 Stocks at 52-Week Lows Poised for a Powerful Rebound - investorplace Wed 10 Apr - GILD - link story | |
Park Place Capital Corp Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD) - themarketsdaily Fri 5 Apr - GILD - link story | |
Park Place Capital Corp Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD) - dailypolitical Fri 5 Apr - GILD - link story | |
Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows - fool Fri 5 Apr - GILD - link story | |
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lowered by Coastline Trust Co - theenterpriseleader Wed 3 Apr - GILD - link story | |
Farmers & Merchants Investments Inc. Sells 237 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - tickerreport Wed 3 Apr - GILD - link story | |
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress - Galapagos (NASDAQ:GLPG) - benzinga Mon 1 Apr - GILD - link story | |
Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD) - streetinsider Thu 28 Mar - GILD - link story | |
Xilio Therapeutics Plans Private Placement, Job Cuts - marketscreener Thu 28 Mar - GILD - link story | |
Gilead Sciences (NASDAQ:GILD) Stock Rating Upgraded by StockNews.com - theenterpriseleader Thu 28 Mar - GILD - link story | |
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 - prnewswire Thu 28 Mar - GILD - link story | |
Gilead man dies in Jefferson County crash, officials say - journalstar Wed 27 Mar - GILD - link story | |
Bill Few Associates Inc. Lowers Holdings in Gilead Sciences, Inc. (NASDAQ:GILD) - dailypolitical Mon 25 Mar - GILD - link story | |
Gilead Sher | The Age - theage au Mon 18 Mar - GILD - link story | |
Good news: Brain cancer researchers make a breakthrough - deccanherald Sun 17 Mar - GILD - link story | |
Gilead Sciences : Kite Cell Therapy Analyst & Investor Event -March 14, 2024 at 06:41 pm EDT - marketscreener Fri 15 Mar - GILD - link story | |
AHF • Protesters Keep Heat on Greedy Gilead over Price Gouging - aidshealth org Wed 13 Mar - GILD - link story | |
Protesters Keep Heat on Greedy Gilead over Price Gouging - valdostadailytimes Wed 13 Mar - GILD - link story | |
Protesters Keep Heat on Greedy Gilead over Price Gouging - streetinsider Wed 13 Mar - GILD - link story | |
Judge slaps down Big Pharma's attack on drug price cuts - dominionpost Sun 10 Mar - GILD - link story | |
Gilead Sciences Signs Yet Another R&D Alliance for Multi-Target Cancer Therapies - medcitynews Thu 7 Mar - GILD - link story | |
Zidovudine Market SWOT Analysis by Leading Key Players: Gilead - openpr Tue 27 Feb - GILD - link story | |
Certified Advisory Corp Sells 593 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) - theenterpriseleader Fri 23 Feb - GILD - link story | |
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 - investorplace Fri 23 Feb - GILD - link story | |
Gilead pauses enrollment for solid tumor trials of cancer drug on high mortality risk - seekingalpha Fri 16 Feb - GILD - link story | |
Gilead Sciences: 2024 Catalysts Should Drive Growth And Change In Sentiment (NASDAQ:GILD) - seekingalpha Fri 16 Feb - GILD - link story | |
The Market share for Epclusa by Gilead Sciences Set to Experience - openpr Thu 15 Feb - GILD - link story | |
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FANG, CBAY, WISH - eagletribune Tue 13 Feb - GILD - link story | |
Itch a wrap: Cymabay PBC story ends with $4.3B Gilead buy - bioworld Tue 13 Feb - GILD - link story | |
News Highlights: Top Company News of the Day - Monday at 7 PM ET - marketscreener Tue 13 Feb - GILD - link story | |
Gilead Sciences | PressReleasePoint - pressreleasepoint Sat 10 Feb - GILD - link story | |
Upsized Kyverna IPO Gets $319M to Bring CAR T-Therapy to Autoimmune Diseases - medcitynews Fri 9 Feb - GILD - link story | |
Gilead Discontinues Phase 3 ENHANCE-3 Trial of Magrolimab Plus Venetoclax/Azacitidine in AML - onclive Fri 9 Feb - GILD - link story | |
Gilead Ends Development of Magrolimab for Hematologic Cancers - empr Fri 9 Feb - GILD - link story | |
Gilead Sciences Full Year 2023 Earnings: EPS Misses Expectations - yahoo Thu 8 Feb - GILD - link story | |
AHF • AHF Hammers Gilead Over Continued Profiteering - aidshealth org Thu 8 Feb - GILD - link story | |
Gilead will decide March 30 on building updates at town meeting - sunjournal Thu 8 Feb - GILD - link story |